Lung cancer

therapeutic options for stage IV and recurrent NSCLC.

A. R. Calvo, Chandra Belani

Research output: Contribution to journalReview article

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)189-227
Number of pages39
JournalCancer treatment and research
Volume105
StatePublished - Jan 1 2001

Fingerprint

Local Neoplasm Recurrences
Alkylating Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Teniposide
Taxoids
Camptothecin
Combined Modality Therapy
Phase III Clinical Trials
Deoxycytidine
Phase II Clinical Trials
Vinblastine
Carboplatin
Etoposide
Paclitaxel
Non-Small Cell Lung Carcinoma
Cisplatin
Multicenter Studies
Lung Neoplasms
Randomized Controlled Trials
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{654958bb95a5442d8588e98b4708cc7a,
title = "Lung cancer: therapeutic options for stage IV and recurrent NSCLC.",
author = "Calvo, {A. R.} and Chandra Belani",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "105",
pages = "189--227",
journal = "Cancer Treatment and Research",
issn = "0927-3042",
publisher = "Springer Netherlands",

}

Lung cancer : therapeutic options for stage IV and recurrent NSCLC. / Calvo, A. R.; Belani, Chandra.

In: Cancer treatment and research, Vol. 105, 01.01.2001, p. 189-227.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Lung cancer

T2 - therapeutic options for stage IV and recurrent NSCLC.

AU - Calvo, A. R.

AU - Belani, Chandra

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=0035221315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035221315&partnerID=8YFLogxK

M3 - Review article

VL - 105

SP - 189

EP - 227

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

SN - 0927-3042

ER -